| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
2,387,705 |
0.00 |
0.00 |
2,387,705 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
1,151,540 |
0.00 |
0.00 |
1,290,428 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
2,155,765 |
0.00 |
0.00 |
2,294,653 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
10,000,000 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
7,807,026 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
2,502,252 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
796,380 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
530,920 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
5,289,322 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
3,526,215 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
303,360 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
1,450,614 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
10,266,152 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
2,387,705 |
0.00 |
0.00 |
2,387,705 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
1,151,540 |
0.00 |
0.00 |
1,290,428 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
2,155,765 |
0.00 |
0.00 |
2,294,653 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
10,000,000 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
7,807,026 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
2,502,252 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
796,380 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
530,920 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
5,289,322 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
3,526,215 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
303,360 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
1,450,614 |
0.00 |
0.00 |
0 |